Seven challenges in modeling vaccine preventable diseases

Epidemics

Volumn 10, Issue , 2015, Pages 11-15

  Metcalf, C J E ^a   Andreasen, V ^b   Bjornstad O N ^c   Eames, K ^d   Edmunds, W J ^d   Funk, S ^d   Hollingsworth, T D ^e,f   Lessler, J ^g   Viboud, C ^h   Grenfell, B T ^a,h  

^a PRINCETON UNIVERSITY   (United States)

^b Systems and Models ^*  (Denmark)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e UNIVERSITY OF WARWICK   (United Kingdom)

^f LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Coverage; Elimination; Immunity; Modeling; Vaccination

Indexed keywords

VACCINE;

COMMUNICABLE DISEASE; ECONOMICS; HEALTH CARE POLICY; HUMAN; IMMUNOLOGY; INFECTION CONTROL; INNATE IMMUNITY; PROCEDURES; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES; HEALTH POLICY; HUMANS; IMMUNITY, INNATE; MODELS, STATISTICAL; VACCINES;

EID: 84926220998     PISSN: 17554365     EISSN: 18780067     Source Type: Journal    
DOI: 10.1016/j.epidem.2014.08.004     Document Type: Article

References (40)

1. Antia R., Ganusov V.V., Ahmed R. The role of models in understanding CD8+ T-cell memory. Nat. Rev. Immunol. 2005, 5(2):101-111.
2. Arinaminpathy N., Lavine J.S., Grenfell B.T. Self-boosting vaccines and their implications for herd immunity. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(49):20154-20159.
3. Arinaminpathy N., et al. Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza. Proc. Natl. Acad. Sci. U.S.A. 2012, 109(8):3173-3177.
4. Atkins K.E., et al. Vaccination and reduced cohort duration can drive virulence evolution: Marek's disease virus and industrialized agriculture. Evolution 2013, 67(3):851-860.
5. Bartlett M.S. Measles periodicity and community size. J. R. Stat. Soc. Ser. A (Gen.) 1957, 121:48-70.
6. Bergstrom C.T., Antia R. How do adaptive immune systems control pathogens while avoiding autoimmunity?. Trends Ecol. Evol. 2006, 21(1):22-28.
7. Bolker B., Grenfell B. Space, persistence and dynamics of measles epidemics. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 1995, 348(1325):309-320.
8. Brito D.L., Sheshinski E., Intriligator M.D. Externalities and compulsory vaccinations. J. Public Econ. 1991, 45(1):69-90.
9. Burton A., et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull. World Health Organ. 2009, 87:535-541.
10. Chao D.L., et al. Controlling dengue with vaccines in Thailand. PLoS Negl. Trop. Dis. 2012, 6(10):e1876.
11. Coudeville L., Garnett G.P. Transmission dynamics of the four dengue serotypes in southern Vietnam and the potential impact of vaccination. PLOS ONE 2012, 7(12):e51244.
12. Danon L., et al. Networks and the epidemiology of infectious disease. Interdiscip. Perspect. Infect. Dis. 2011, 2011.
13. Eames K.T. Networks of influence and infection: parental choices and childhood disease. J. R. Soc. Interface 2009, 6(38):811-814.
14. Fine P.E.M., Clarkson J.A. Seasonal influences on pertussis. Int. J. Epidemiol. 1986, 15:237-247.
15. Flasche S., et al. The impact of specific and non-specific immunity on the ecology of Streptococcus pneumoniae and the implications for vaccination. Proc. R. Soc. B: Biol. Sci. 2013, 280(1771):20131939.
16. Funk S., Salathé M., Jansen V.A. Modelling the influence of human behaviour on the spread of infectious diseases: a review. J. R. Soc. Interface 2010, 7(50):1247-1256.
17. Funk S., et al. Challenges in modelling the dynamics of behaviours towards infectious diseases. Epidemics 2014.
18. Grenfell B.T., Bjørnstad O.N., Kappey J. Travelling waves and spatial hierarchies in measles epidemics. Nature 2001, 414:716-723.
19. Halloran M.E., et al. Design and Analysis of Vaccine Studies 2010, Springer.
20. Jansen V.A., et al. Measles outbreaks in a population with declining vaccine uptake. Science 2003, 301(5634):804.
21. Keeling M.J., Bjornstad O.N., Grenfell B.T. Metapopulation dynamics of infectious diseases. Ecology, Genetics and Evolution of Metapopulations 2004, 415-445. Elsevier. I.A. Hanski, O.E. Gaggiotti (Eds.).
22. Klepac P., Laxminarayan R., Grenfell B.T. Synthesizing epidemiological and economic optima for control of immunizing infections. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(34):14366-14370.
23. Klepac P., et al. Six challenges in the eradication of infectious diseases. Epidemics 2014, (in preparation).
24. Knox E.G. Strategy for rubella vaccination. Int. J. Epidemiol. 1980, 9:13-23.
25. Lange A., Ferguson N.M. Antigenic diversity, transmission mechanisms, and the evolution of pathogens. PLoS Computat. Biol. 2009, 5(10):e1000536.
26. Lavine J.S., King A.A., Bjørnstad O.N. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc. Natl. Acad. Sci. U.S.A. 2011, 108(17):7259-7264.
27. Lee B.Y., et al. The impact of making vaccines thermostable in Niger's vaccine supply chain. Vaccine 2012, 30(38):5637-5643.
28. Lessler J., et al. Measuring the performance of vaccination programs using cross-sectional surveys. PLoS Med. 2011, 8:e1001110.
29. McLean A.R., Blower S.M. Modelling HIV vaccination. Trends Microbiol. 1995, 3(12):458-463.
30. Metcalf C.J.E., et al. Five challenges in evolution and infectious disease. Epidemics 2014.
31. Metcalf C.J.E., Lessler J., Edmunds W.J. Six challenges in public health and modeling. Epidemics 2014, (in preparation).
32. Mossong J., et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008, 5:e74.
33. Pilyugin S.S., Antia R. Modeling immune responses with handling time. Bull. Math. Biol. 2000, 62(5):869-890.
34. Plotkin S.A., Orenstein W.A., Offit P.A. Vaccines 2013, Saunders. 6th ed.
35. Rodriguez-Barraquer I., et al. Potential opportunities and perils of imperfect dengue vaccines. Vaccine 2014, 32(4):514-520.
36. Salathé M., Khandelwal S. Assessing vaccination sentiments with online social media: implications for infectious disease dynamics and control. PLoS Comput. Biol. 2011, 7(10):e1002199.
37. Thakar J., et al. Constraint-based network model of pathogen-immune system interactions. J. R. Soc. Interface 2009, 6(36):599-612.
38. Van Kerkhove M.D., et al. Studies needed to address public health challenges of the 2009 H1N1 influenza pandemic: insights from modeling. PLoS Med. 2010, 7(6):e1000275.
39. Weinberger D.M., Malley R., Lipsitch M. Serotype replacement in disease after pneumococcal vaccination. Lancet 2011, 378(9807):1962-1973.
40. Wu J.T., et al. Estimating infection attack rates and severity in real time during an influenza pandemic: analysis of serial cross-sectional serologic surveillance data. PLoS Med. 2011, 8(10):e1001103.